title: Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report.
authors.affiliation: Division of General Internal Medicine, Department of Medicine, University of California-San Francisco.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Tice
authors.affiliation: WHO Collaborating Centre for Pharmaceutical Research and Science Policy, Department of Clinical Pharmacy, University of California-San Francisco.
authors.forename: Harinder S
authors.initials: HS
authors.lastname: Chahal
authors.affiliation: Institute for Clinical and Economic Review, Boston, Massachusetts.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Ollendorf
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D002140:California; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000191:economics* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D007372:Interferons